Ionisoivaan
Ionisoivaan is a synthetic ionophore antibiotic developed by Pfizer. It is used to treat certain types of bacterial infections, particularly those caused by Gram-positive bacteria. Ionisoivaan works by inhibiting the synthesis of bacterial cell walls, leading to the death of the bacteria. It is typically administered intravenously and is often used in combination with other antibiotics to improve treatment efficacy.
The most common side effects of ionisoivaan include nausea, vomiting, diarrhea, and rash. More serious side
Ionisoivaan is generally well-tolerated, but its use should be carefully considered due to the risk of serious